Unexpected Resolution of Stage IV Diffuse Large B-Cell Lymphoma in an HIV-Positive Patient: A Case Study and Review of Existing Literature - Report - MDSpire
Advertisement
Unexpected Resolution of Stage IV Diffuse Large B-Cell Lymphoma in an HIV-Positive Patient: A Case Study and Review of Existing Literature
Clinical Report: Unexpected Resolution of Stage IV Diffuse Large B-Cell Lymphoma
Overview
This report details a rare case of spontaneous regression of stage IV diffuse large B-cell lymphoma (DLBCL) in an HIV-positive patient following the initiation of combination antiretroviral therapy (cART). The patient achieved complete radiographic resolution of hepatic lesions and has maintained remission for over 36 months.
Background
HIV-associated DLBCL is an aggressive malignancy with poor outcomes, particularly in advanced stages. The incidence of non-HIV-related malignancies, including DLBCL, has increased among HIV-positive individuals, highlighting the need for effective management strategies. Understanding the potential for spontaneous regression in this context may provide insights into treatment approaches and patient outcomes.
Data Highlights
No numerical data or trial data available in the article.
Key Findings
A 66-year-old male with stage IV DLBCL achieved spontaneous regression after starting cART.
Complete radiographic resolution of hepatic lesions occurred without cytotoxic therapy.
Remission has been sustained for over 36 months.
CD4+ T-cell recovery was observed, correlating with tumor regression.
Spontaneous regression in HIV-positive patients with DLBCL is exceedingly rare.
Early initiation of cART is recommended to restore immune function in HIV-positive lymphoma patients.
Clinical Implications
This case emphasizes the importance of early cART initiation in HIV-positive patients with lymphoma, as it may enhance immune recovery and potentially influence tumor outcomes. Clinicians should consider the implications of immune reconstitution in managing HIV-associated malignancies.
Conclusion
The spontaneous regression of DLBCL in an HIV-positive patient underscores the critical role of immune reconstitution through cART. This case may inform future clinical practices and research in the management of HIV-associated lymphomas.
